Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06988189

Unmasking Concealed Arrhythmia Syndromes

Status
Recruiting
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Imperial College London · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Accepted

Summary

This study seeks to evaluate whether using non-invasive electrocardiograph (ECG) techniques, including long term ECG monitoring with wearable ECGs, can improve the detection of concealed Brugada syndrome.

Detailed description

Application of long term continuous ECG monitoring via ECG wearables and ambulatory ECG monitors to detect manifestations of Brugada syndrome. This approach will be combined with development of an AI (artificial intelligence) enabled ECG platform to automate Brugada ECG detection and analysis. The protocol will comprise the following parts: Study A: Brugada ECG AI development. This will automate the recognition of the type 1 Brugada ECG pattern on 12 lead ECGs. Study B: Remote arrhythmia diagnostics. A prospective observational study whereby recruited participants will be fitted with a wearable ECG or cardiac monitor to undergo continuous long term ambulatory ECG monitoring. The algorithms developed in study A will be applied to long term ECG data captured in this study. Study C: Arrhythmic risk stratification using ultra-high-frequency ECG. This exploratory study will look for markers of arrhythmic risk in patients with manifest and concealed arrhythmia syndromes.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TEST12-lead ECG12-lead ECG from a conventional ECG machine
DIAGNOSTIC_TESTContinuous long term ambulatory ECG monitoringContinuous long term ambulatory ECG monitoring using wearable ECG or cardiac monitor
DIAGNOSTIC_TESTUltra-high-frequency ECGUltra-high-frequency ECG acquired using specific acquisition equipment

Timeline

Start date
2024-09-09
Primary completion
2026-11-01
Completion
2026-11-01
First posted
2025-05-23
Last updated
2025-05-23

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT06988189. Inclusion in this directory is not an endorsement.